Molecular basis of iron-loading disorders

Deepak Darshan; David M. Frazer; Gregory J. Anderson

doi:10.1017/S1462399410001687

Molecular basis of iron-loading disorders

Published online by Cambridge University Press: 08 November 2010

Deepak Darshan ,

David M. Frazer and

Gregory J. Anderson

Show author details

Deepak Darshan: Affiliation:
Iron Metabolism Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
David M. Frazer: Affiliation:
Iron Metabolism Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
Gregory J. Anderson*: Affiliation:
Iron Metabolism Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
*: *Corresponding author: Gregory J. Anderson, Iron Metabolism Laboratory, Queensland Institute of Medical Research, Royal Brisbane Hospital, Brisbane, Queensland 4029, Australia. E-mail: greg.anderson@qimr.edu.au

Article contents

Abstract
References

Get access

Rights & Permissions

Abstract

Iron-loading disorders (haemochromatosis) represent an important class of human diseases. Primary iron loading results from inherited disturbances in the mechanisms regulating intestinal iron absorption, such that excess iron is taken up from the diet. Body iron load can also be increased by repeated blood transfusions (secondary iron loading), usually as part of the treatment for various haematological disorders. In these syndromes, an element of enhanced iron absorption is also often involved. The central regulator of body iron trafficking is the liver-derived peptide hepcidin. Hepcidin limits iron entry into the plasma from macrophages, intestinal enterocytes and other cells by binding to the sole iron-export protein ferroportin, and facilitating its removal from the plasma membrane. Mutations in hepcidin or its upstream regulators (HFE, TFR2, HFE2 and BMP6) lead to reduced or absent hepcidin expression and a concomitant increase in iron absorption. Mutations in ferroportin that prevent hepcidin binding produce a similar result. Increased ineffective erythropoiesis, which often characterises erythrocyte disorders, also leads to reduced hepcidin expression and increased absorption. Recent advances in our understanding of hepcidin and body iron homeostasis provide the potential for a range of new diagnostic and therapeutic tools for haemochromatosis and related conditions.

Type: Review Article
Information: Expert Reviews in Molecular Medicine , Volume 12 , January 2010 , e36

DOI: https://doi.org/10.1017/S1462399410001687 [Opens in a new window]
Copyright: Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Zimmermann, M.B. and Hurrell, R.F. (2007) Nutritional iron deficiency. Lancet 370, 511-520CrossRef Google Scholar PubMed

2O'Neil, J. and Powell, L. (2005) Clinical aspects of hemochromatosis. Seminars in Liver Disease 25, 381-391CrossRef Google Scholar PubMed

3Lee, P.L. and Beutler, E. (2009) Regulation of hepcidin and iron-overload disease. Annual Review of Pathology 4, 489-515CrossRef Google Scholar PubMed

4Gattermann, N. (2009) The treatment of secondary hemochromatosis. Deutsches Arzteblatt International 106, 499-504Google Scholar PubMed

5Rechavi, G. and Rivella, S. (2008) Regulation of iron absorption in hemoglobinopathies. Current Molecular Medicine 8, 646-662CrossRef Google Scholar PubMed

6Forth, W. and Rummel, W. (1973) Iron absorption. Physiological Reviews 53, 724-792CrossRef Google Scholar PubMed

7Brittenham, G.M. (1994) The red cell cycle. In Iron Metabolism in Health & Disease (Brock, J.H., Halliday, J.W. and Pippard, M.J., eds), pp. 31-62, W.B. Saunders Company Ltd, London, UKGoogle Scholar

8Powell, L.W., Jazwinska, E. and Halliday, J.W. (1994) Primary iron overload. In Iron Metabolism in Health and Disease (Brock, J.H., Halliday, J.W. and Pippard, M.J., eds), pp. 227-270, W.B. Saunders Company Ltd, London, UKGoogle Scholar

9McKie, A.T. et al. (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291, 1755-1759CrossRef Google Scholar PubMed

10Fleming, M.D. et al. (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proceedings of National Academy of Sciences USA 95, 1148-1153CrossRef Google Scholar PubMed

11Gunshin, H. et al. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488CrossRef Google Scholar PubMed

12Abboud, S. and Haile, D.J. (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. Journal of Biological Chemistry 275, 19906-19912CrossRef Google Scholar PubMed

13Donovan, A. et al. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781CrossRef Google Scholar PubMed

14McKie, A.T. et al. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Molecular Cell 5, 299-309CrossRef Google Scholar PubMed

15Vulpe, C.D. et al. (1999) Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nature Genetics 21, 195-199CrossRef Google Scholar PubMed

16Conrad, M.E. Jr and Crosby, W.H. (1963) Intestinal mucosal mechanisms controlling iron absorption. Blood 22, 406-415CrossRef Google Scholar PubMed

17Conrad, M.E., Weintraub, L.R. and Crosby, W.H. (1964) The role of the intestine in iron kinetics. Journal of Clinical Investigation 43, 963-974CrossRef Google Scholar PubMed

18Frazer, D.M. et al. (2003) A rapid decrease in the expression of DMT1 and Dcytb but not Ireg1 or hephaestin explains the mucosal block phenomenon of iron absorption. Gut 52, 340-346CrossRef Google Scholar PubMed

19Chen, H. et al. (2003) Systemic regulation of hephaestin and Ireg1 revealed in studies of genetic and nutritional iron deficiency. Blood 102, 1893-1899CrossRef Google Scholar PubMed

20Huebers, H.A. and Finch, C.A. (1987) The physiology of transferrin and transferrin receptors. Physiological Reviews 67, 520-582CrossRef Google Scholar PubMed

21Anderson, G.J. et al. (2007) Regulation of systemic iron homeostasis: how the body responds to changes in iron demand. Biometals 20, 665-674CrossRef Google Scholar PubMed

22Donovan, A. et al. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metabolism 1, 191-200CrossRef Google Scholar PubMed

23Nemeth, E. and Ganz, T. (2009) The role of hepcidin in iron metabolism. Acta Haematologica 122, 78-86CrossRef Google Scholar PubMed

24Nemeth, E. et al. (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation 113, 1271-1276CrossRef Google Scholar

25Allen, K.J. et al. (2008) Iron-overload-related disease in HFE hereditary hemochromatosis. New England Journal of Medicine 358, 221-230CrossRef Google Scholar PubMed

26Neves, J.V. et al. Hemochromatosis and pregnancy: iron stores in the Hfe-/- mouse are not reduced by multiple pregnancies. American Journal of Physiology Gastrointestinal and Liver Physiology 298, G525-G529CrossRef Google Scholar

27Benyamin, B. et al. (2009) Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. American Journal of Human Genetics 84, 60-65CrossRef Google Scholar PubMed

28Galaris, D. and Pantopoulos, K. (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Critical Reviews in Clinical Laboratory Sciences 45, 1-23CrossRef Google Scholar PubMed

29Ramm, G.A. and Ruddell, R.G. (2005) Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Seminars in Liver Disease 25, 433-449CrossRef Google Scholar PubMed

30Camaschella, C. et al. (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nature Genetics 25, 14-15CrossRef Google Scholar

31Chloupkova, M., Zhang, A.S. and Enns, C.A. (2010) Stoichiometries of transferrin receptors 1 and 2 in human liver. Blood Cells Molecules and Diseases 44, 28-33CrossRef Google Scholar PubMed

32Kawabata, H. et al. (2000) Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. Journal of Biological Chemistry 275, 16618-16625CrossRef Google Scholar PubMed

33Fleming, R.E. et al. (2002) Targeted mutagenesis of the murine transferrin receptor-2 gene produces hemochromatosis. Proceedings of the National Academy of Sciences of the United States of America 99, 10653-10658CrossRef Google Scholar PubMed

34Kawabata, H. et al. (2005) Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105, 376-381CrossRef Google Scholar PubMed

35Nemeth, E. et al. (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105, 1803-1806CrossRef Google Scholar PubMed

36Pietrangelo, A. (2005) Non-HFE hemochromatosis. Seminars in Liver Disease 25, 450-460CrossRef Google Scholar PubMed

37Wallace, D.F. et al. (2009) Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50, 1992-2000CrossRef Google Scholar PubMed

38De Gobbi, M. et al. (2002) Natural history of juvenile haemochromatosis. British Journal of Haematology 117, 973-979CrossRef Google Scholar PubMed

39Papanikolaou, G. et al. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nature Genetics 36, 77-82CrossRef Google Scholar PubMed

40Roetto, A. et al. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nature Genetics 33, 21-22CrossRef Google Scholar PubMed

41De Domenico, I. et al. (2006) Iron overload due to mutations in ferroportin. Haematologica 91, 92-95Google Scholar PubMed

42McCance, R.A. and Widdowson, E.M. (1937) Absorption and excretion of iron. Lancet ii, 5Google Scholar

43Yang, L.P., Keam, S.J. and Keating, G.M. (2007) Deferasirox : a review of its use in the management of transfusional chronic iron overload. Drugs 67, 2211-2230CrossRef Google Scholar PubMed

44Vichinsky, E. (2008) Clinical application of deferasirox: practical patient management. American Journal of Hematology 83, 398-402CrossRef Google Scholar PubMed

45Li, H. et al. (2010) Transferrin therapy ameliorates disease in beta-thalassemic mice. Nature Medicine 16, 177-182CrossRef Google Scholar PubMed

46Wheby, M.S. (1978) Medicinal iron-induced hepatic cirrhosis: reversal by phlebotomy: studies on pathogenesis. Transactions of the American Clinical and Climatological Association 89, 100-108Google Scholar PubMed

47Gordeuk, V.R. (2002) African iron overload. Seminars in Hematology 39, 263-269CrossRef Google Scholar PubMed

48Hamill, R.L., Woods, J.C. and Cook, B.A. (1991) Congenital atransferrinemia. A case report and review of the literature. American Journal of Clinical Pathology 96, 215-218CrossRef Google Scholar PubMed

49Morita, H. et al. (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Annals of Neurology 37, 646-656CrossRef Google Scholar PubMed

50Whitington, P.F. (2007) Neonatal hemochromatosis: a congenital alloimmune hepatitis. Seminars in Liver Disease 27, 243-250CrossRef Google Scholar PubMed

51Deugnier, Y. and Turlin, B. (2007) Pathology of hepatic iron overload. World Journal of Gastroenterology 13, 4755-4760CrossRef Google Scholar PubMed

52Sarkany, R.P. (2001) The management of porphyria cutanea tarda. Clinical Experimental Dermatology 26, 225-232CrossRef Google Scholar PubMed

53Hutchinson, C. et al. (2008) Post-prandial iron absorption in humans: comparison between HFE genotypes and iron deficiency anaemia. Clinical Nutrition 27, 258-263CrossRef Google Scholar PubMed

54McLaren, G.D. et al. (1991) Regulation of intestinal iron absorption and mucosal iron kinetics in hereditary hemochromatosis. Journal of Laboratory Clinical Medicine 117, 390-401Google Scholar PubMed

55Cazzola, M. et al. (1983) Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Human Genetics 65, 149-154CrossRef Google Scholar PubMed

56Bridle, K.R. et al. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669-673CrossRef Google Scholar PubMed

57Spasic, M.V. et al. (2008) Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metabolism 7, 173-178CrossRef Google Scholar

58Vujic Spasic, M. et al. (2007) Physiologic systemic iron metabolism in mice deficient for duodenal Hfe. Blood 109, 4511-4517CrossRef Google Scholar PubMed

59Babitt, J.L. et al. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nature Genetics 38, 531-539CrossRef Google Scholar PubMed

60Chen, D., Zhao, M. and Mundy, G.R. (2004) Bone morphogenetic proteins. Growth Factors 22, 233-241CrossRef Google Scholar PubMed

61Xia, Y. et al. (2008) Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 111, 5195-5204CrossRef Google Scholar

62Truksa, J. et al. (2009) Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6. British Journal of Haematology 147, 571-581CrossRef Google Scholar PubMed

63Wang, R.H. et al. (2005) A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metabolism 2, 399-409CrossRef Google Scholar PubMed

64Mleczko-Sanecka, K. et al. (2010) SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood 115, 2657-2665CrossRef Google Scholar PubMed

65Babitt, J.L. et al. (2007) Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. Journal of Clinical Investigation 117, 1933-1939CrossRef Google Scholar PubMed

66Andriopoulos, B. Jr. et al. (2009) BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nature Genetics 41, 482-487CrossRef Google Scholar PubMed

67Meynard, D. et al. (2009) Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nature Genetics 41, 478-481CrossRef Google Scholar PubMed

68Kautz, L. et al. (2008) Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112, 1503-1509CrossRef Google Scholar PubMed

69Lee, D.H. et al. (2010) Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood 115, 3136-3145CrossRef Google Scholar PubMed

70Zhang, A.S. et al. (2009) Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4-induced hepcidin expression. Journal of Biological Chemistry 284, 22580-22589CrossRef Google Scholar PubMed

71Du, X. et al. (2008) The serine protease TMPRSS6 is required to sense iron deficiency. Science 320, 1088-1092CrossRef Google Scholar PubMed

72Lin, L., Goldberg, Y.P. and Ganz, T. (2005) Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106, 2884-2889CrossRef Google Scholar PubMed

73Silvestri, L., Pagani, A. and Camaschella, C. (2008) Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111, 924-931CrossRef Google Scholar PubMed

74Zhang, A.S. et al. (2007) Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. Journal of Biological Chemistry 282, 12547-12556CrossRef Google Scholar PubMed

75Folgueras, A.R. et al. (2008) Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112, 2539-2545CrossRef Google Scholar PubMed

76Finberg, K.E. et al. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nature Genetics 40, 569-571CrossRef Google Scholar PubMed

77Guillem, F. et al. (2008) Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. Blood 112, 2089-2091CrossRef Google Scholar

78Chambers, J.C. et al. (2009) Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nature Genetics 41, 1170-1172CrossRef Google Scholar PubMed

79Ganesh, S.K. et al. (2009) Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nature Genetics 41, 1191-1198CrossRef Google Scholar PubMed

80Tanaka, T. et al. (2010) A genome-wide association analysis of serum iron concentrations. Blood 115, 94-96CrossRef Google Scholar PubMed

81Silvestri, L. et al. (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metabolism 8, 502-511CrossRef Google Scholar PubMed

82Finberg, K.E. et al. (2010) Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. Blood 115, 3817-3826CrossRef Google Scholar PubMed

83Frazer, D.M. et al. (2004) Delayed hepcidin response explains the lag period in iron absorption following a stimulus to increase erythropoiesis. Gut 53, 1509-1515CrossRef Google Scholar PubMed

84Peyssonnaux, C. et al. (2007) Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). Journal of Clinical Investigation 117, 1926-1932CrossRef Google Scholar PubMed

85Tanno, T. et al. (2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114, 181-186CrossRef Google Scholar PubMed

86Tanno, T. et al. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nature Medicine 13, 1096-1101CrossRef Google Scholar PubMed

87Kanda, J. et al. (2008) Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica 93, 1550-1554CrossRef Google Scholar PubMed

88Chang, C. et al. (2001) Twisted gastrulation can function as a BMP antagonist. Nature 410, 483-487CrossRef Google Scholar PubMed

89Ross, J.J. et al. (2001) Twisted gastrulation is a conserved extracellular BMP antagonist. Nature 410, 479-483CrossRef Google Scholar PubMed

90Nicolas, G. et al. (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. Journal of Clinical Investigation 110, 1037-1044CrossRef Google Scholar PubMed

91Agarwal, N. and Prchal, J.T. (2009) Anemia of chronic disease (anemia of inflammation). Acta Haematologica 122, 103-108CrossRef Google Scholar PubMed

92Wrighting, D.M. and Andrews, N.C. (2006) Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204-3209CrossRef Google Scholar PubMed

93Wilkins, S.J. et al. (2006) Iron metabolism in the hemoglobin-deficit mouse: correlation of diferric transferrin with hepcidin expression. Blood 107, 1659-1664CrossRef Google Scholar PubMed

94Huebers, H. et al. (1985) Molecular advantage of diferric transferrin in delivering iron to reticulocytes: a comparative study. Proceedings Proceedings of the Society for Experimental Biology and Medicine 179, 222-226CrossRef Google Scholar PubMed

95Buys, S.S. et al. (1991) Iron absorption in hypotransferrinemic mice. Blood 78, 3288-3290CrossRef Google Scholar PubMed

96Weinstein, D.A. et al. (2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776-3781CrossRef Google Scholar PubMed

97Johnson, M.B. and Enns, C.A. (2004) Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104, 4287-4293CrossRef Google Scholar PubMed

98Gao, J. et al. (2009) Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metabolism 9, 217-227CrossRef Google Scholar PubMed

99Ramey, G., Deschemin, J.C. and Vaulont, S. (2009) Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica 94, 765-772CrossRef Google Scholar PubMed

100West, A.P. Jr et al. (2001) Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. Journal of Molecular Biology 313, 385-397CrossRef Google Scholar PubMed

101Schmidt, P.J. et al. (2008) The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metabolism 7, 205-214CrossRef Google Scholar PubMed

102Andrews, N.C. (2008) Forging a field: the golden age of iron biology. Blood 112, 219-230CrossRef Google Scholar PubMed

103Calzolari, A. et al. (2006) TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. Journal of Cell Science 119, 4486-4498CrossRef Google Scholar PubMed

104Niederkofler, V., Salie, R. and Arber, S. (2005) Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. Journal of Clinical Investigation 115, 2180-2186CrossRef Google Scholar PubMed

105Nicolas, G. et al. (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proceedings of the National Academy of Sciences of theUnited States of America 98, 8780–8785CrossRef Google Scholar

106Bayele, H.K., McArdle, H. and Srai, S.K. (2006) Cis and trans regulation of hepcidin expression by upstream stimulatory factor. Blood 108, 4237-4245CrossRef Google Scholar PubMed

107Bridle, K. et al. (2006) Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcoholism: Clinical and Experimental Research 30, 106-112CrossRef Google Scholar PubMed

108Harrison-Findik, D.D. et al. (2006) Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. Journal of Biological Chemistry 281, 22974-22982CrossRef Google Scholar PubMed

109Flanagan, J.M., Peng, H. and Beutler, E. (2007) Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations. Alcoholism: Clinical and Experimental Research 31, 138-143CrossRef Google Scholar PubMed

110Bayele, H.K. and Srai, S.K. (2009) Regulatory variation in hepcidin expression as a heritable quantitative trait. Biochemical and Biophysical Research Communications 384, 22-27CrossRef Google Scholar PubMed

111Andreani, M. et al. (2009) Association of hepcidin promoter c.-582 A > G variant and iron overload in thalassemia major. Haematologica 94, 1293-1296CrossRef Google Scholar

112Piperno, A. et al. (2007) Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110, 4096-4100CrossRef Google Scholar PubMed

113van Dijk, B.A. et al. (2008) Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels. British Journal of Haematology 142, 979-985CrossRef Google Scholar PubMed

114Knittel, T. et al. (1997) Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1. Experimental Cell Research 232, 263-269CrossRef Google Scholar PubMed

115Theurl, I. et al. (2008) Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111, 2392-2399CrossRef Google Scholar PubMed

116Nicolas, G. et al. (2003) Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nature Genetics 34, 97-101CrossRef Google Scholar

117Laftah, A.H. et al. (2004) Effect of hepcidin on intestinal iron absorption in mice. Blood 103, 3940-3944CrossRef Google Scholar PubMed

118Chung, B. et al. (2009) Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells. Journal of Nutrition 139, 1457-1462CrossRef Google Scholar PubMed

119Nemeth, E. (2010) Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Advances in Hematology 2010, 750643, doi: 10.1155/2010/750643CrossRef Google Scholar PubMed

120Paradkar, P.N. et al. (2008) Iron depletion limits intracellular bacterial growth in macrophages. Blood 112, 866-874CrossRef Google Scholar PubMed

121Gao, J. et al. (2010) Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood 115, 3374-3381CrossRef Google Scholar PubMed

122Sasu, B.J. et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood 115, 3616-3624CrossRef Google Scholar

123Ludwiczek, S. et al. (2007) Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nature Medicine 13, 448-454CrossRef Google Scholar PubMed

124Oudit, G.Y. et al. (2003) L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nature Medicine 9, 1187-1194CrossRef Google Scholar

125Sugishita, K. et al. (2009) A case of iron overload cardiomyopathy: beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction. International Heart Journal 50, 829-838CrossRef Google Scholar PubMed

126Ganz, T. et al. (2008) Immunoassay for human serum hepcidin. Blood 112, 4292-4297CrossRef Google Scholar PubMed

127Grebenchtchikov, N. et al. (2009) High-sensitive radioimmunoassay for human serum hepcidin. British Journal of Haematology 146, 317-325CrossRef Google Scholar PubMed

128Busbridge, M. et al. (2009) Development of a novel immunoassay for the iron regulatory peptide hepcidin. British Journal of Biomedical Science 66, 150-157CrossRef Google Scholar PubMed

129Ward, D.G. et al. (2008) SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. Proteome Science 6, 28CrossRef Google Scholar PubMed

130Kemna, E. et al. (2005) Novel urine hepcidin assay by mass spectrometry. Blood 106, 3268-3270CrossRef Google Scholar PubMed

131Murphy, A.T. et al. (2007) Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 110, 1048-1054CrossRef Google Scholar PubMed

132Li, H. et al. (2009) Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. Journal of Pharmacological and Toxicological Methods 59, 171-180CrossRef Google Scholar PubMed

133Kroot, J.J. et al. (2009) Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 94, 1748-1752CrossRef Google Scholar PubMed

134Iqbal, T. et al. (2009) Is iron overload in alcohol-related cirrhosis mediated by hepcidin? World Journal of Gastroenterology 15, 5864-5866CrossRef Google Scholar PubMed

135Peters, H.P. et al. (2010) Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrology, Dialysis, Transplantation 25, 848-853CrossRef Google Scholar PubMed

136van Deuren, M., Kroot, J.J. and Swinkels, D.W. (2009) Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist. Haematologica 94, 1297-1300CrossRef Google Scholar

137Young, M.F. et al. (2009) Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. American Journal of Clinical Nutrition 89, 533-538CrossRef Google Scholar PubMed

Article contents

Molecular basis of iron-loading disorders

Abstract

Access options

References

References

Further reading, resources and contacts

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Article contents

Molecular basis of iron-loading disorders

Abstract

Access options

References

References

Further reading, resources and contacts

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests